US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 2.280
  • -0.440-16.18%
Close Dec 10 16:00 ET
259.68MMarket Cap-1.39P/E (TTM)

Fate Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 30, 2024

Based on 12 analysts giving stock ratings to Fate Therapeutics in the past 3 months

Buy

  • Buy

    25.00%

  • Hold

    75.00%

  • Sell

    0.00%

Price Target

Updated: Nov 30, 2024

The average Fate Therapeutics stock price target is 5.50 with a max estimate of 10.00 and a min estimate of 3.00

Review Fate Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    25.00%

  • Hold

    75.00%

  • Sell

    0.00%

Price Target

Updated: Nov 30, 2024

Heat List
US
Overall
Symbol
Price
% Chg

No Data